Piper Sandler analysts are cautioning investors about a potential correction in the S&P 500, despite recent highs. Their note ...

In a note released Friday, analysts at Piper Sandler weighed in on the matter. The analysts discussed Harris’s recent speech ...

As you can see from the chart above the percentage of shares that are sold short for Piper Sandler has grown since its last report. This does not mean that the stock is going to fall in the near ...

Piper Sandler underscores the importance of taking Trump seriously on trade. Trade-related ideas account for about one-third ...

Piper Sandler analysts put out a list of companies that show three weeks of improving “TechniGrade” ranking within their ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

JMP Securities analyst Devin Ryan maintained a Hold rating on Piper Sandler (PIPR – Research Report) today. The company’s shares closed yesterday at $271.44. According to TipRanks, Ryan is a ...

Piper Sandler analyst Adam Maeder maintained a Hold rating on Axonics Modulation Technologies (AXNX – Research Report) today and set a price target of $71.00. The company’s shares closed ...

Nancy Lazar, Piper Sandler global chief economist, joins 'Money Movers' to discuss whether Tuesday's economic data changes any of the economists' forecasts, whether the Federal Reserve has room to ...

Investing.com -- Piper Sandler initiated coverage on Abbott Laboratories (NYSE:ABT) with an "overweight" rating and a price target of $131 per share. Piper Sandler emphasizes Abbott’s ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...